Searchable abstracts of presentations at key conferences in endocrinology

ea0090p130 | Pituitary and Neuroendocrinology | ECE2023

Increased Plasma Leptin and Agouti-Related Peptide May Be Related To Sleep Alterations In Patients With Active Cushing’s Syndrome

Sulu Cem , Mefkure Ozkaya Hande , Kadioglu Pinar

Aim: To evaluate sleep architecture of patients with Cushing’s disease (CD) and to explore whether agouti-related peptide (AgRP) leptin, and interleukin-6 (IL-6) play a permissive role in sleep alterations.Methods: We performed polysomnography on 26 patients with active CD and age 26 age- and sex-matched control subjects. Blood samples were obtained from all participants for the analyses of AgRP, leptin, and IL-6. The laboratory and sleep-related pa...

ea0090p159 | Pituitary and Neuroendocrinology | ECE2023

Mild Autonomous Cortisol Secretion May Be Related To Decreased Thalamic Volume

Sulu Cem , Kadioglu Pinar , Mefkure Ozkaya Hande

Aim: To investigate the volumetric changes in cortical and subcortical deep gray matter (GM) structures and cognitive alterations in patients with mild autonomous cortisol secretion (MACS). We also sought to assess whether the anticipated changes in brain volume and cognitive functions of the patients with MACS differ from the changes in patients with overt Cushing’s Syndrome (CS). Methods: In this cross-sectional study, volumes of the cortex, hippo...

ea0056p317 | Clinical case reports - Thyroid/Others | ECE2018

Diabetic ketoacidosis occurring in the patient whom newly started insulin glargine U300: a case report

Onur Kirac Cem , Ipekci Suleyman , Kebapcilar Levent

Basal insulin secretion is essential for the maintenance of fasting glucose levels, especially through inhibition of excessive hepatic glucose output. Insulin glargine U300 is a novel long acting basal insulin formulation that provides more stable effect than glargine U100. Because of the pharmacokinetic properties of glargine U300, the expected plasma insulin concentration is not achieved during the first 4 days of treatment. We report a case of diabetic ketoacidosis in the f...

ea0022p148 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Searching for the metabolic syndrome criteria in young adults with hypogonadism

Sonmez Alper , Haymana Cem , Bolu Erol , Tapan Serkan , Barcin Cem , Aydogdu Aydogan , Taslipinar Abdullah , Kutlu Mustafa

Introduction: The evidence shows that the prevalence of metabolic syndrome is increased in patients with hypogonadism. However, much of the data regarding this association comes from the elderly patients with obesity, hypertension or type 2 diabetes. The total testosterone levels alter physiologically in these conditions and thus can falsify the association. We aimed to investigate the prevalence of the metabolic syndrome in young adults with hypogonadism who do not have any c...

ea0090p792 | Thyroid | ECE2023

Plasma Lipoprotein(a) Is Not Associated With Graves’ Ophthalmopathy

Sulu Cem , Dedeoglu Selin , Gonen Busenur , Gonen Sait

Aim: To investigate the relation of serum lipoprotein (a) (Lp(a)) and other serum lipids with presence of Graves’ Ophthalmopathy (GO). We also analyzed the correlation between serum lipids and GO activity.Methods: A cross-sectional investigation was conducted in consecutive patients with Graves’ Disease (GD) who came under the authors’ observation to receive antithyroid drug. A stratification was aimed at forming two distinct groups of pat...

ea0090ep774 | Pituitary and Neuroendocrinology | ECE2023

The role of artificial intelligence algorithm in predicting the prognosis in prolactinomas

Kara Zehra , Sulu Cem , Demir Ahmet Numan , Kadioglu Pinar

Objective: To test the utility of the artificial learning algorithms using magnetic resonance (MR) images of the pituitary gland in predicting the prognosis of prolactinoma.Methods: This single-center, retrospective study was conducted in the Pituitary Center of a tertiary care university hospital. A total of 224 images derived from 38 patients with treatment-refractory prolactinoma, 23 patients with prolactinoma remission and 51 healthy individuals were...

ea0049ep256 | Calcium & Vitamin D metabolism | ECE2017

Spontaneous remission of parathyroid adenoma due to parathyroid apoplexy: a case report

Kirac Cem Onur , Baldane Suleyman , Ipekci Suleyman , Kebapcilar Levent

Introduction: Primary hyperparathyroidism (PHPT) is a disease that is characterized by elevated calcium and parathyroid hormone levels. The most common cause of PHPT is the paratiroid adenoma and the first line treatment option is surgical removal of the adenoma. Rarely, the haemorrhage in the lesion may cause the spontaneous remission of the disease.Case report: A 54-year-old woman patient with fatigue was referred to our department due to calcium level...

ea0049ep1214 | Clinical case reports - Thyroid/Others | ECE2017

Papillary thyroid microcarcinoma in struma ovarii tissue: a case report

Kirac Cem Onur , Baldane Suleyman , Ipekci Suleyman , Kebapcilar Levent

Introduction: Struma ovarii is an uncommon ovarian neoplasm that more than half of itself is made up of thyroid tissue. In clinical trials about the disease, malign transformation has been detected at the rate of 0.5–5%. Because of the disease’s rareness, there is no absolute agreement about diagnosis and treatment of the disease.Case report: A 33-year-old woman admitted to gynecology department with abdominal pain. Her pelvic MR revealed 147&#...

ea0035p465 | Diabetes therapy | ECE2014

Metabolic control of our turkish diabetic patients on exenatide therapy: good at metabolic control but how about compliance?

Mirili Cem , Yurekli Banu Sarer , Kocabas Gokcen Unal , Kaya Zubeyde

Objective: Our aim is to evaluate the effect of exenatide treatment on body weight, HbA1c and compliance to treatment.Material and method: A total of 36 (five M and 31 F) type 2 diabetic patients who were prescribed exenatide were evaluated for this study. Body weight, BMI, HbA1c parameters and side effects were noted from the outpatient clinic records.Result: The median age of our patients was 52 years of old (19–79 years). M...

ea0056p985 | Clinical case reports - Thyroid/Others | ECE2018

A silent thyroiditis in the remission period of Graves’ disease

Kirac Cem Onur , Ipekci Suleyman , Gedik Gonca Kara , Kebapcilar Levent

Silent thyroiditis is characterized by the destructive thyroid inflammation and is considered to be a chronic autoimmune thyroid disease, although the etiology could not have been fully explained. On the other hand, Graves’ disease is autoimmune phenomena as well as silent thyroiditis and silent thyroiditis has been classified as part of the spectrum of Graves’ disease. Although, the thyroid stimulating antibody (TSAb) are found positive in most of Graves’ disea...